Penile brachytherapy: Technical aspects and postimplant issues

被引：34

作者：

Crook, Juanita ^{[1
]}

Jezioranski, John ^{[2
]}

Cygler, Joanna E. ^{[3
]}

机构：

[1] Univ Toronto, Dept Radiat Oncol, Princess Margaret Hosp, Toronto, ON, Canada

[2] Univ Hlth Network, Dept Radiat Phys, Princess Margaret Hosp, Toronto, ON, Canada

[3] Ottawa Hosp, Ctr Canc, Dept Med Phys, Ottawa, ON, Canada

来源：

BRACHYTHERAPY | 2010年 / 9卷 / 02期

关键词：

Penile cancer; Interstitial brachytherapy; Brachytherapy technique; SQUAMOUS-CELL CARCINOMA; INTERSTITIAL BRACHYTHERAPY; RADIATION-THERAPY; EXPERIENCE; CANCER; WIRES;

D O I：

10.1016/j.brachy.2009.05.005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PURPOSE: Squamous carcinoma (SCC) of the penis affects about 1 in 100,000 men in western societies. Interstitial brachytherapy can be an effective penis-conserving modality for T1, T2, and selected T3 tumors. Unfortunately, few radiation oncology trainees have the opportunity to treat a case of penile cancer during their residency, and few centers have brachytherapy expertise for this tumor site. We report our technique that has been developed and refined over the past 20 years. MATERIALS AND METHODS: From 1989 to 2009, we have been using brachytherapy to treat penile SCC and have experience with 75 cases. From 1989 to 1998, manual afterloading was used with (192)Ir wire or seeds, and from 1999 to the present, pulse dose rate automated afterloading. Sixty Gray is delivered over a period of 4-5 days. RESULTS: Patient selection for penile brachytherapy and the technical and dosimetric aspects of the procedure will be discussed along with posttreatment care and followup. CONCLUSIONS: Brachytherapy is an effective treatment for T1, T2, and selected T3 SCC of the penis. Efficacy depends on careful planning and appreciation of dosimetry. (C) 2010 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.

引用

页码：151 / 158

页数：8

共 20 条

[1] Interstitial brachytherapy in carcinoma of the penis [J].

Chaudhary, AJ ;

Ghosh, S ;

Bhalavat, RL ;

Kulkarni, JN ;

Sequeira, BVE .

STRAHLENTHERAPIE UND ONKOLOGIE, 1999, 175 (01) :17-20

[2] Interstitial brachytherapy for penile cancer: An alternative to amputation [J].

Crook, J ;

Grimard, L ;

Tsihlias, J ;

Morash, C ;

Panzarella, T .

JOURNAL OF UROLOGY, 2002, 167 (02) :506-511

[3] Penile brachytherapy: Results for 49 patients [J].

Crook, JM ;

Jezioranski, J ;

Math, M ;

Grimard, L ;

Esche, B ;

Pond, G .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (02) :460-467

[4] Radiation therapy in the management of the primary penile tumor: an update [J].

Crook, Juanita ;

Ma, Clement ;

Grimard, Laval .

WORLD JOURNAL OF UROLOGY, 2009, 27 (02) :189-196

[5] The clinical radiobiology of brachytherapy [J].

Dale, RG ;

Jones, B .

BRITISH JOURNAL OF RADIOLOGY, 1998, 71 (845) :465-483

[6]

DELANNES M, 1992, INT J RADIAT ONCOL, V24, P479

[7]

GRAHAM JH, 1973, CANCER-AM CANCER SOC, V32, P1396, DOI 10.1002/1097-0142(197312)32:6<1396::AID-CNCR2820320618>3.0.CO

[8]

2-T

[9] PENILE CANCER-CHEMOTHERAPY - 12 YEARS EXPERIENCE AT INSTITUT GUSTAVE-ROUSSY [J].

KATTAN, J ;

COURT, B ;

CULINE, S ;

PERRIN, JL ;

DROZ, JP ;

WIBAULT, P ;

FADEL, E ;

HAIEMEDER, C .

UROLOGY, 1993, 42 (05) :559-562

[10] Iridium-192 implantation for node-negative carcinoma of the penis: The Cookridge hospital experience [J].

Kiltie, AE ;

Elwell, C ;

Close, HJ ;

Ash, DV .

CLINICAL ONCOLOGY, 2000, 12 (01) :25-31

← 1 2 →